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Arginine-vasopressin (AVP) stimulated the formation of labelled phosphatidic a id (PA) in [14C]arachidonic 
acid-prelabelled rat Leydig cells. After addition of 10 -6 M AVP [14C]arachidonoylphosphatidic acid reached 
a maximum within 2 min. The increase was dose-dependent (10-H_ 10-6 M). No change in labelling of other 
phospholipids and diacylglycerol could be detected. The V1 antagonist dPTyr(Me)AVP inhibited in a dose- 
dependent manner the AVP-stimulated accumulation fPA. The V2 agonist dPVDAVP was without effect. 
The present results suggest that AVP binds to Vl receptors in rat Leydig cells resulting in stimulation of 
PA turnover. We suggest that the AVP-stimulated PA formation isan indication of phosphoinositide turn- 
over. 
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1. INTRODUCTION 
The neurohypophysial nonapeptide AVP is 
known to act via at least two distinct receptors [1]. 
The V1 receptor is assumed to be coupled to the 
calcium-phosphoinositide system (hepatocytes [2]; 
smooth muscle cell line [3], platelets [4]; mesangial 
cells [5]) whereas there is evidence that the V2 
receptor is linked to adenylate cyclase [1]. 
It has been demonstrated that an AVP-like pep- 
tide is present in rat testes [6]. As specific AVP 
receptors of the V~ type have been located in 
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Leydig cells [7] and as an inhibitory effect of AVP 
on human chorionic gonadotropin-stimulated 
steroidogenesis [8] has been demonstrated, it is of 
interest o study the mechanism by which the AVP 
signal is transduced across the plasma membrane 
in Leydig cells. 
We have studied the turnover of [14C]arach- 
idonoylphospholipids in rat Leydig cells during 
stimulation of the cells with AVP, with dPTyr- 
(Me)AVP (a VI antagonist) and with dPVDAVP (a 
V2 agonist). 
2. MATERIALS AND METHODS 
2.1. Materials 
dPVDAVP, dPTyr(Me)AVP, bovine serum 
albumin (essentially fatty acid-free) and col- 
lagenase (type IA) were from Sigma (St. Louis, 
MO). [l-14C]Arachidonic acid (59.6 mCi/mmol) 
was from Amersham International (England). 
Fetal calf serum was from Gibco (Paisley, 
Scotland). Lipid standards were from Serdary 
Research Laboratories (London, Ontario). Silica 
gel 60, high-performance thin-layer plates were 
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from Merck (Darmstadt). AVP was from A/B Fer- 
ring (Maims, Sweden). 
water and 1.0 ml Aqualuma R (Lumax Application 
Laboratory, The Netherlands). 
2.2. Methods 
Sprague-Dawley rats (35-40 days old) from 
Molleghrd (Lille Skensved, Denmark) were used. 
Leydig cells were obtained after collagenase 
(0.1070) treatment of decapsulated testes as de- 
scribed [9,10]. The cells were allowed to attach to 
Costar multiwell dishes (diameter 35 mm) in 2 ml  
Krebs-Ringer bicarbonate buffer containing 0.2°70 
(w/v) glucose (KRB) supplemented with 1 070 (v/v) 
fetal calf serum. Incubations were carried out at 
32°C under air/CO2 (95:5, v/v). 
After 1 h the buffer was removed and the cells 
attached to the dishes were used for the ex- 
periments [120.0 + 34.8/zg protein/well, mean _+ 
SD (n = 14)]. Cells were incubated with 
[14C]arachidonic acid (2 × 105 cpm/well) in KRB 
containing 0.05070 (w/v) defatted bovine serum 
albumin. After incubation for 1 h the cells were 
washed in 1.5 ml KRB containing 0.5070 (w/v) 
defatted bovine serum albumin, and once in 2 ml 
KRB. 
Peptides were added and the cells were in- 
cubated as described in section 3. Immediately 
after removal of the medium the ceils were lysed 
with 2 ml ice-cold 1 N HC1 and harvested. The cell 
suspensions were sonicated and an aliquot was 
used for protein determination after neutralization 
with NaOH [11]. The remainder (1.5 ml) was ex- 
tracted with 4 ml chloroform/methanol (2: 1) con- 
taining PA (3 nmol/tube) and DG (3 nmol/tube). 
The lower phase was collected and the upper phase 
was reextracted with 2 ml chloroform. The com- 
bined extracts were evaporated under nitrogen. 
The residue was resuspended in chloroform/ 
methanol (2: 1). An aliquot was used for liquid 
scintillation counting. The rest was applied to a 
high-performance thin-layer plate. The plates were 
developed with chloroform/acetone/methanol/  
acetic acid/water (40:15:13:12:8, v/v) to a 
distance of 8 cm above the application line, and 
then with hexane/diethyl ether/acetic acid (70: 
30:2, v/v) to a distance of 15 cm. The lipids were 
visualized after spraying with 10070 (w/v) copper 
sulfate in 8070 (w/v) aqueous phosphoric acid and 
charring at 180°C for 10 min [12]. Spots were 
compared to standards, scraped into liquid scintil- 
lation vials and counted in a mixture of 0.1 ml 
3. RESULTS AND DISCUSSION 
The distribution of [14C]arachidonic a id among 
the neutral lipids and phospholipids in 
unstimulated rat Leydig cells is shown in table 1. 
The label was incorporated mainly in the 
phospholipids. 
Exposure to AVP (10 -6 M) induced a rapid rise 
in labelled PA (fig. 1). Within 2 min the labelling in 
PA reached a maximum 1-2-fold over control. It 
was necessary to add PA as carrier before extrac- 
tion in order to obtain maximum recovery of en- 
dogenous PA. Under the circumstances of these 
experiments we could not with certainty detect 
changes in labelling of other phospholipids (not 
shown). Even with addition of DG as carrier prior 
to lipid extraction o change in the level of labelled 
Table 1 
Distribution of [~4C]arachidonic a id in rat Leydig cell 
lipids 
Lipid class Radioactivity 
(°70 of total 
incorporated) 
Free fatty acid 
Diacylglycerol 
Triacylglycerol 
Phosphatidic acid 
Phosphatidylethanolamine 
Phosphatidylcholine + 
phosphatidylserine 
Phosphatidylinositol 
Phosphatidylinositol 4-phosphate + 
phosphatidylinositol 
4,5-bisphosphate 
Others 
2.3 +_ 0.6 
1.7 +_ 0.4 
4.4 _+ 0.6 
0.9 _+ 0.1 
10.8 +_ 1.6 
42.8 _+ 1.1 a 
27.0 +_ 1.7 a 
2.5 +_ 0.5 
7.2 _+ 1.0 
a For these phospholipids the results are from only two 
experiments, as in the third experiment phosphatidyl- 
inositol cochromatographed with phosphatidylcholine 
+ phosphatidylserine 
Rat Leydig cells were incubated with [14C]arachidonic 
acid for 1 h, washed and incubated for 2 min with 
medium only. The lipids were extracted and separated as 
described in section 2. Results are means +_ SD of three 
experiments 
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Fig.l. Effect of AVP with time on labelled PA 
accumulation. Rat Leydig cells were preincubated with 
[~4C]arachidonic acid for 60 rain and then incubated in 
the absence (o) or presence (o) of AVP (10 -6 M). One 
experiment, typical of four, is shown, each value in 
duplicate. Results (~4C in PA) are expressed as the 
percentage of cpm incorporated in the total lipid extract 
per mg protein. 
Fig.3. Effect of increasing AVP and V2 agonist 
dPVDAVP concentrations on [*4C]arachidonoyl-PA 
formation. Rat Leydig cells, prelabelled with 
[~4C]arachidonic acid, were incubated for 2 min in the 
absence (0) or presence of either AVP (o) or 
dPVDAVP (i). One experiment, typical of three, is 
shown, each value in duplicate. For other details, see the 
legend to fig. 1. 
DG was observed between 10 s and 5 min (not 
shown). This is in contrast to studies in rat 
mesangial ceils [5] where stimulation with AVP in- 
duces an increase in both [14C]arachidonic acid- 
labelled DG and PA for up to 5 min after stimula- 
tion. The lack of changes in DG could be due to 
the fact that DG is rapidly phosphorylated to PA. 
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Fig.2. Effect of increasing AVP concentrations on 
[~4C]arachidonoyl-PA formation. Rat Leydig cells were 
preincubated with [~4C]arachidonic acid for 60 min and 
then incubated for 2 min in the absence (o) or presence 
(o) of AVP. For other details, see the legend to fig. 1. 
Formation of PA has been used to monitor 
phospholipase C activity [13]. 
The effect of AVP was dose-dependent (fig.2) in 
the range 10-11-10-6M. In contrast, the V2 
agonist dPVDAVP did not affect the amount of 
labelled PA (fig.3). dPVDAVP was used in a con- 
..,~ //. i i i r i ) • 
"E 
-g_ ,~ 
u O. 
C~ 
. t -  
O o .  
20 
10 
0 -9 -8 -7 -6 -5 
Concentration (log [M]) 
o 
o 
I 
c 
Fig.4. Inhibition by the V~ antagonist dPTyr(Me)AVP 
on AVP induced [14C]arachidonoyl-PA formation. Cells 
were incubated with different amounts of 
dPTyr(Me)AVP for 2 min in the absence (n) or presence 
of 10 -6 M AVP (e). C, control (medium only) (o). For 
other details, see the legend to fig.3. 
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centration range where it can displace [3H]AVP 
binding to Leydig cells [7]. 
The stimulatory effect of AVP (10 -6 M) on for- 
mation of labelled PA was abolished by the V1 an- 
tagonist dPTyr(Me)AVP in a dose-dependent 
manner (fig.4). When dPTyr(Me)AVP was added 
to Leydig cells alone it stimulated a small response, 
indicating that it could be a partial agonist. 
Our results suggest hat AVP binds to V~ recep- 
tors in rat Leydig cells resulting in stimulation of 
PA turnover. Although in the time range studied 
we could not detect changes in the labelling of 
other lipids, including PI,  P IP  + PIP2 and DG, we 
suggest on the basis of studies in other cell types 
[1-5] that the AVP-stimulated PA formation is an 
indication of phosphatidylinositol turnover. 
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